Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

33.77
Delayed Data
As of Jun 27
 -0.27 / -0.79%
Today’s Change
29.83
Today|||52-Week Range
37.39
+3.97%
Year-to-Date
AstraZeneca's Faslodex Recommended by CHMP for 1st Line Use
Jun 27 / Zacks.com - Paid Partner Content
Samsung Could Sell More Drugs
Jun 23 / TheStreet.com - Paid Partner Content
Sanofi/Regeneron's Kevzara Gets Marketing Approval in EU
Jun 27 / Zacks.com - Paid Partner Content
15 Great Dividend Stocks to Own Should the Surging Stock Market Plunge This Summer
Jun 23 / TheStreet.com - Paid Partner Content
Epizyme Progressing Well on Two Lead Pipeline Candidates
Jun 26 / Zacks.com - Paid Partner Content
Stocks to Fight Cancer: Why Immunotherapy Is a Gamechanger
Jun 22 / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: Boeing Bags Big Orders at Paris Air Show; Wal-Mart to Buy Bonob...
Jun 23 / Zacks.com - Paid Partner Content
Stock Market News for June 22, 2017
Jun 22 / Zacks.com - Paid Partner Content
Biotech Movers: Regeneron Slides Back After Big Gains
Jun 23 / TheStreet.com - Paid Partner Content
Merck's Keytruda on a Roll: Can it Retain the Momentum?
Jun 22 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close34.04
Today’s open34.13
Day’s range33.75 - 34.13
Volume15,265,637
Average volume (3 months)22,543,324
Market cap$201.1B
Dividend yield3.79%
Data as of 06/27/2017

Growth & Valuation

Earnings growth (last year)+5.09%
Earnings growth (this year)+6.25%
Earnings growth (next 5 years)+5.75%
Revenue growth (last year)+8.13%
P/E ratio28.4
Price/Sales3.79
Price/Book3.44

Competitors

 Today’s
change
Today’s
% change
NVSNovartis-0.44-0.51%
MRKMerck-0.38-0.58%
SNYSanofi-0.30-0.60%
ABBVAbbVie-0.35-0.48%
Data as of 06/27/2017

Financials

Next reporting dateAugust 1, 2017
EPS forecast (this quarter)$0.65
Annual revenue (last year)$52.8B
Annual profit (last year)$7.2B
Net profit margin13.63%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
Chairman &
Chief Executive Officer
Ian C. Read
Chief Financial Officer &
EVP-Business Operations
Frank A. D'Amelio
Corporate headquarters
New York, New York

Forecasts